GPD1 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP8507a
Background:
GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.
Other Names:
Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, GPD-C, GPDH-C, GPD1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8507a was selected from the N-term region of human GPD1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: GPD1 (HGNC:4455)
Gene ID: 2819
Primary Accession: P21695
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.
Other Names:
Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, GPD-C, GPDH-C, GPD1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8507a was selected from the N-term region of human GPD1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: GPD1 (HGNC:4455)
Gene ID: 2819
Primary Accession: P21695
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review